Multiple Wall Street institutions are optimistic about Anthropic, with Melius setting a target price of $155
Anthropic set the IPO issue price at $83 per share. Four Wall Street firms, Citizens, Wolfe Research, Needham, and Melius, initiated coverage on the stock, all giving bullish ratings with target prices ranging from $125 to $155, approximately 51% to 87% higher than the issue price.
Among them, Citizens gave a "Outperform" rating with a target price of $125; Wolfe Research gave an "Outperform" rating with a target price of $135; both Needham and Melius gave a "Buy" rating with target prices of $150 and $155, respectively.
Needham expects that Anthropic's revenue growth for the fiscal year 2027 will exceed 150% and believes that the company's gross margin and operating margin are expected to exceed 90% and 35%, respectively. Melius believes that the widespread adoption of AI applications and the decrease in computing costs will support the company's long-term earnings potential of over $5 per share. Citizens is optimistic about its multi-chip infrastructure, a strong founding team, and software development driven by Claude.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.






